American Vanguard Third Quarter 2026 Earnings Conference Call - AMERICAN VANGUARD CORP

Financial Performance:

• Q3 2026 net sales reached $108 million, a 9% decline year-over-year; YTD sales were $349 million (-4%).
• Adjusted EBITDA was approximately break-even for Q3 2026, down $8.3 million from the prior year.
• Gross margin contracted to 24.2% in Q3 2026 from 28.7% in Q3 2025, negatively impacted by 250 basis points from freight costs, raw material inflation, and lower fixed cost leverage.
• Cash balance increased to $84 million (up $40 million sequentially) driven by a 44% surge in customer prepayments; inventory reduced by $4.9 million year-over-year.
• Total debt stands at $267.7 million with net debt at $183.8 million; gross leverage ratio is 6.5x, nearing the 6.7x covenant maximum.
• Non-GAAP operating expenses were $34.2 million, including $3 million in amortization, $3 million in transformation costs, and $300k in stock-based compensation.

Guidance and Future Outlook:

• Full-year 2026 revenue guidance lowered to $500–$530 million (previously $530–$550 million); adjusted EBITDA guidance lowered to $36–$40 million (previously $44–$48 million).
• Q4 2026 is projected to generate net sales of approximately $166 million (+10% YoY) and adjusted EBITDA of $21 million (+25% YoY), driven by volume recovery and cost savings.
• Long-term goal set to reach an annualized revenue run rate of over $600 million by the back half of 2028 (approx. 20% above 2025 levels).
• Management targets moving EBITDA margins into double digits as soon as possible, with a strategic focus on reducing net debt to enable attractive refinancing by 2028.

Business Segments and Product Lines:

• U.S. Crop sales were down 2% in Q3, offset by growth in growth regulators (Folex, Citrus Fix) and fungicides, partially negated by declines in soil fumigants and herbicides.
• U.S. Specialty sales decreased 2% due to lower ornamental sales, though turf fungicide and mosquito adulticide (Naled) showed growth; YTD U.S. Specialty sales are up 6%.
• International sales declined 17% in Q3 (14% YTD) primarily due to El Niño weather effects in Latin America.
• New product pipeline includes 10 launches YTD; Q4 launch expected for "Duro LQ," a liquid corn insecticide.
• Strategic goal remains 50 new product launches to drive $100 million in annualized revenue by 2030.

Market and Competitive Landscape:

• Global agricultural markets face headwinds from Middle East conflict, high interest rates, and El Niño-induced droughts and flooding.
• U.S. farmers face pressure from high input costs (fuel up 80% YTD, fertilizer) and low commodity prices; government aid now accounts for ~40% of net farm income.
• Latin America (Central America, Mexico, Brazil) suffered from adverse weather, low crop prices, intense generic competition, and political uncertainty.
• Australia performed well due to label extensions for the "Flute" fungicide product.
• Distributors and retailers maintain lean inventories and purchase on an as-needed basis across all geographies.

Risks and Challenges:

• Rising transportation costs (diesel prices up >40% in Q3 alone) are eroding gross margins and delaying price pass-throughs.
• Climate volatility (Super El Niño) continues to disrupt planting and harvest schedules in key international markets.
• Inability to fully offset inflationary raw material and fuel costs with pricing increases in the current quarter.
• Geopolitical instability in the Middle East affecting input costs and global supply chains.

Management Commentary and Tone:

• CEO Dak Kay and CFO Matt Horwath emphasized "controlling what we can control" regarding execution despite external macro headwinds.
• Tone remained confident in the company's ability to outperform peers and deliver operating leverage from recent cost initiatives (LA facility closure, HQ relocation).
• Management highlighted a renewed focus on R&D, new product execution, and strategic acquisitions to drive future growth.
• CFO Matt Horwath expressed strong confidence in the path to sustainable financial growth, operational excellence, and free cash flow generation.

Analyst Questions and Answers:

• Analyst Jeff Bronchik asked about the recent $5 million acquisition of Syngenta products and the associated $15–$20 million annualized revenue projection.
• CEO Kay confirmed the acquisition includes four niche crop brands with U.S. registrations, higher-margin branded products, and technical rights for mixtures; combined with a SIPCAM Agro distribution agreement, the total revenue impact is $15–$20 million.
• Management clarified that the acquisition and distribution revenue are baked into the Q4 2026 projections alongside organic new product launches (e.g., Duro LQ).
• When asked about the certainty of Q4 guidance, management stated the commercial plan is energized but not fully "baked in" due to industry dynamics, relying on a focused execution strategy.

Other Key Points:

• Completed operational footprint rationalization: LA manufacturing moved to Alabama (saving ~$4M/year) and HQ relocated to Irvine (saving ~$0.5M/year).
• Leadership changes include the appointment of Mark Helt as U.S. Crop President, Matt Horwath as CFO, and Herman Castro to drive new product development.
• Management noted that Q3 saw a shift in cotton portfolio sales timing, with herbicide and soil insecticide sales impacted by timing versus the prior year.
• The company is prioritizing a reduction in net working capital and inventory turns to improve cash flow efficiency.